- Home
- CCEL vs CNTB Comparison
CCEL vs CNTB Comparison
Compare CCEL & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- CNTB
- Stock Information
- Founded
- CCEL 1989
- CNTB 2012
- Country
- CCEL United States
- CNTB United States
- Employees
- CCEL N/A
- CNTB N/A
- Industry
- CCEL Managed Health Care
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- CNTB Health Care
- Exchange
- CCEL Nasdaq
- CNTB Nasdaq
- Market Cap
- CCEL 50.0M
- CNTB 53.9M
- IPO Year
- CCEL 1997
- CNTB 2021
- Fundamental
- Price
- CCEL $7.40
- CNTB $1.05
- Analyst Decision
- CCEL
- CNTB Strong Buy
- Analyst Count
- CCEL 0
- CNTB 1
- Target Price
- CCEL N/A
- CNTB $8.00
- AVG Volume (30 Days)
- CCEL 13.7K
- CNTB 28.0K
- Earning Date
- CCEL 02-26-2025
- CNTB 09-05-2024
- Dividend Yield
- CCEL 3.38%
- CNTB N/A
- EPS Growth
- CCEL N/A
- CNTB N/A
- EPS
- CCEL N/A
- CNTB N/A
- Revenue
- CCEL $31,838,476.00
- CNTB $24,116,000.00
- Revenue This Year
- CCEL $3.97
- CNTB N/A
- Revenue Next Year
- CCEL $0.91
- CNTB $63.90
- P/E Ratio
- CCEL N/A
- CNTB N/A
- Revenue Growth
- CCEL 1.95
- CNTB N/A
- 52 Week Low
- CCEL $4.47
- CNTB $0.90
- 52 Week High
- CCEL $9.50
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- CCEL 46.30
- CNTB 45.74
- Support Level
- CCEL $6.74
- CNTB $1.01
- Resistance Level
- CCEL $7.50
- CNTB $1.40
- Average True Range (ATR)
- CCEL 0.42
- CNTB 0.13
- MACD
- CCEL -0.02
- CNTB -0.01
- Stochastic Oscillator
- CCEL 56.42
- CNTB 25.53
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.